An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer
Clinical trial NCT00214838 · UNKNOWN
Trial details
- NCT number
- NCT00214838
- Sponsor
- Callisto Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.